Ecliptal, a promising natural lead isolated fromEclipta albamodulates adipocyte function and ameliorates metabolic syndrome

    loading  Checking for direct PDF access through Ovid


A swift increase has been observed in the number of individuals with metabolic syndrome worldwide. A number of natural compounds have been identified towards combating metabolic syndrome. Adding to this premise, here we report the pleiotropic activities of Ecliptal (EC); a natural compound isolated from the herb Eclipta alba. Administration of EC was shown to have prominent anti-adipogenic effects in 3T3-L1 and hMSC derived adipocytes. It was shown to activate Wnt-pathway and alter AKT signaling. Additionally, it caused cell cycle arrest and inhibited mitotic clonal expansion. EC treatment augmented mitochondrial biogenesis as well as function as estimated by expression of PGC1α, UCP-1, mitochondrial complexes and estimation of oxygen consumption rate. EC also reduced LPS-induced inflammation and tunicamycin induced ER stress. Further, EC enhanced insulin sensitivity by increasing AKT phosphorylation, inhibiting PKCα/βII phosphorylation and reducing leptin/adiponectin ratio. Finally, EC administration in Syrian golden hamsters was shown to have potent anti-dyslipidemic effects. Cumulatively, encompassing pleiotropic activities of EC, it could prove to be a potential drug candidate against obesity, insulin resistance and related metabolic syndrome.Graphical abstractHighlightsEcliptal shows prominent anti-adipogenic effects.Ecliptal blocked mitotic clonal expansion.Ecliptal treatment augmented mitochondrial functions.Ecliptal exhibited anti-inflammatory and anti-ER stress activities.In-vivo, Ecliptal was shown to have anti-dyslipidemic effects too.

    loading  Loading Related Articles